Browsing by Author Huan, Xiaojun
Showing results 1 to 1 of 1
Issue Date | Title | Author(s) |
23-Nov-2021 | Updated Safety and Efficacy Results of Phase 1 Study of Olverembatinib (HQP1351), a Novel Third -Generation BCR-ABL Tyrosine Kinase Inhibitor (TKI), in Patients with TKI-Resistant Chronic Myeloid Leukemia (CML) | Qian, Jiang; Shi, Dayu; Li, Zongru; Qin, Yazhen; Zhao, Ting; Liu, Bingcheng; Chen, Zi; Niu, Qian; Men, Lichuang; Wang, Hengbang; Yang, Dajun; Zhai, Yifan; Huan, Xiaojun |